Scott Kathleen D.

CIK 00017942844 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001794284

Recent Transactions

30 trades

Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2026-01-02+240,000→ 240,000 total
Award
Dermata Therapeutics, Inc.$DRMA
Stock Option (Right to Buy)
2026-01-02+2,500→ 2,500 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-08-21−12,500→ 739,830 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-08-21$15.00/sh−12,500→ 10,042 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-08-21$1.50/sh+12,500→ 22,542 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-05-20$1.50/sh+50,000→ 57,424 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-05-20$14.10/sh−50,000→ 7,424 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-05-20−50,000→ 752,330 total
Award
Dermata Therapeutics, Inc.$DRMA
Stock Option (Right to Buy)
2025-01-13+5,000→ 5,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2025-01-02+176,700→ 176,700 total
Award
NKGen Biotech, Inc.
Stock Option (right to buy)
2024-12-06+300,000→ 300,000 total
Award
NKGen Biotech, Inc.
Stock Option (right to buy)
2024-12-06+500,000→ 500,000 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-16$1.50/sh+12,500→ 17,449 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-16$16.00/sh−12,500→ 4,949 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-10-16−12,500→ 802,330 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$16.00/sh−12,500→ 13,199 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$1.50/sh+12,500→ 25,699 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-08-20−12,500→ 814,830 total
Award
NKGen Biotech, Inc.
Stock Option (right to buy)
2024-02-12+300,000→ 300,000 total
Award
Dermata Therapeutics, Inc.$DRMA
Stock Option (Right to Buy)
2024-01-04+10,000→ 10,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2024-01-02+200,000→ 200,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2023-01-03+50,000→ 50,000 total
Purchase
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2022-11-29$6.24/sh+8,250→ 8,250 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Employee Stock Option (right to buy)
2022-11-08+827,330→ 827,330 total
Award
Dermata Therapeutics, Inc.$DRMA
Common Stock
2022-10-06+11,359→ 27,145 total
Award
Dermata Therapeutics, Inc.$DRMA
Common Stock
2022-07-07+9,960→ 15,786 total
Award
Dermata Therapeutics, Inc.$DRMA
Common Stock
2022-04-07+5,826→ 5,826 total
Award
Dermata Therapeutics, Inc.$DRMA
Stock Option (right to buy)
2022-01-03+5,000→ 5,000 total
Award
Dermata Therapeutics, Inc.$DRMA
Stock Option (right to Buy)
2021-08-17+10,000→ 10,000 total
Award
Histogen Inc.
Stock Option (Right to Buy)
2019-11-18+30,000→ 30,000 total

Companies

Recent Filings

Address

3525 DEL MAR HEIGHTS RD., #322

SAN DIEGO, CA, 92130

View on SEC.gov